Comparison of Bloodstream Infections With Carbapenem Hetero-resistant vs Carbapenem Resistant Klebsiella Pneumoniae

计划入组 300 人 · 首次发布于 2020 年 1 月 18 日

Limited Versus No-limited Shoulder Movement in Breast Cancer Surgery

计划入组 465 人 · 首次发布于 2019 年 1 月 8 日

Limited-duration Teclistamab

计划入组 75 人 · 首次发布于 2023 年 7 月 6 日

Hetero-DS

Tenecteplase biosimilar (Hetero Biopharma)

Tocilizumab biosimilar(Hetero Biopharma)

HETERO DRUGS LIMITED

India

HETERO LABS LIMITED

India

HETERO BIOPHARMA LIMITED

India

Hetero Healthcare and Enzene Launch Perzea, India's Most Affordable Pertuzumab Biosimilar for HER2-Positive Breast Cancer

AbbVie Sues Hetero Labs Over New Orilissa Patent to Block Generic Endometriosis Drug

Catalyst Pharmaceuticals Settles FIRDAPSE Patent Litigation with Hetero Labs, Securing Market Exclusivity Until 2035